These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 1196229

  • 1. Letter: Fattening of parkinsonians: a hypothalamic side effect of L-dopa?
    Gasparini M, Spinnler H.
    Med J Aust; 1975 Oct 11; 2(15):617. PubMed ID: 1196229
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Effect of L-dopa on EEG tracings in patients with parkinsonism].
    Rudkowska A, Misztal S.
    Pol Tyg Lek; 1975 Apr 07; 30(14):593-5. PubMed ID: 1129202
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease.
    Devos D, Labyt E, Derambure P, Bourriez JL, Cassim F, Reyns N, Blond S, Guieu JD, Destée A, Defebvre L.
    Brain; 2004 Feb 07; 127(Pt 2):408-19. PubMed ID: 14691060
    [Abstract] [Full Text] [Related]

  • 9. [Modification of disturbed visual-spatial performance in patients with Parkinson's disease by treatment with L-dopa].
    Jacobi P, Schneider E, Gundelsheimer W, Fischer PA.
    Nervenarzt; 1974 Nov 07; 45(11):588-94. PubMed ID: 4453348
    [No Abstract] [Full Text] [Related]

  • 10. [Early or late onset of L-dopa treatment in Parkinson disease?].
    von Kummer R, Schneevoigt K.
    Nervenarzt; 1986 Nov 07; 57(11):634-9. PubMed ID: 3808131
    [No Abstract] [Full Text] [Related]

  • 11. Short-term effect of a single levodopa dose on micturition disturbance in Parkinson's disease patients with the wearing-off phenomenon.
    Uchiyama T, Sakakibara R, Hattori T, Yamanishi T.
    Mov Disord; 2003 May 07; 18(5):573-8. PubMed ID: 12722172
    [Abstract] [Full Text] [Related]

  • 12. [Trans-cerebral electrophoresis of L-DOPA in the complex treatment of parkinsonism].
    Neĭmark EZ, Evtushenko SK, Dukhovnaia MA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984 May 07; 84(9):1334-8. PubMed ID: 6506979
    [Abstract] [Full Text] [Related]

  • 13. Changes in the motor response to acute L-dopa challenge after unilateral microelectrode-guided posteroventral pallidotomy.
    Merello M, Nouzeilles MI, Cammarotta A, Pikielny R, Leiguarda R.
    Clin Neuropharmacol; 1998 May 07; 21(2):135-8. PubMed ID: 9579303
    [Abstract] [Full Text] [Related]

  • 14. L-dopa plus dopa-decarboxylase inhibitor. Sleep organization in Parkinson's syndrome before and after treatment.
    Bergonzi P, Chiurulla C, Gambi D, Mennuni G, Pinto F.
    Acta Neurol Belg; 1975 May 07; 75(1):5-10. PubMed ID: 1202895
    [Abstract] [Full Text] [Related]

  • 15. [Use of the preparation L-dopa in parkinsonism].
    Proniv DI, Sirotina OS, Bukhovtsev PP, Mis'kiv IaI.
    Vrach Delo; 1976 Jan 07; (1):113-6. PubMed ID: 1246837
    [No Abstract] [Full Text] [Related]

  • 16. [Aspects of long-term treatment with levodopa alone and levodopa combined with dopa decarboxylase inhibitors].
    Cinca I, Serbănescu A, Tudorache B.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1982 Jan 07; 27(4):261-70. PubMed ID: 6222452
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of Parkinson's disease with orphenadrine alone and in combination with L-dopa.
    Bassi S, Albizzati MG, Calloni E, Sbacchi M, Frattola L.
    Br J Clin Pract; 1986 Jul 07; 40(7):273-5. PubMed ID: 3741741
    [No Abstract] [Full Text] [Related]

  • 18. [Effect of apomorphine on the bladder of parkinsonian patients].
    Aranda B, Cramer P, Adba MA.
    J Urol (Paris); 1992 Jul 07; 98(1):25-9. PubMed ID: 1527394
    [Abstract] [Full Text] [Related]

  • 19. Treatment of Parkinson's disease: levodopa as the first choice.
    Katzenschlager R, Lees AJ.
    J Neurol; 2002 Sep 07; 249 Suppl 2():II19-24. PubMed ID: 12375059
    [Abstract] [Full Text] [Related]

  • 20. The effect of dopaflex on the clinical picture and reaction time of parkinsonian patients.
    Antal J.
    Ther Hung; 1974 Sep 07; 22(2):70-8. PubMed ID: 4419534
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.